Skip to main content

MoneyWorks4Me

Vilco Pharma submits disclosure

02 Jan 2017 Evaluate

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vilco Pharma.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Redington 359.80
Adani Enterprises 2735.00
Amrapali Industries 33.78
Maxgrow India 182.35
Rashi Peripheral 698.70
View more..